Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Taber

Showing results (91-100 of 209) with videos related to

Pageof 21
Sort By:
Progress in Transplantation (Aliso Viejo, Calif.)|April 12, 2023
A Randomized Control Trial Testing a Medication Safety Dashboard in Veteran Transplant RecipientsDavid J Taber, Sherry Milfred-LaForest, Kelsey Rife, et al.
Primary Care Diabetes|April 30, 2023
Sulfonylureas as second line therapy for type 2 diabetes among veterans: Results from a National Longitudinal Cohort StudyErin R Weeda, Ralph Ward, Mulugeta Gebregziabher, et al.
Pharmacotherapy|May 27, 2015
African-American race modifies the influence of tacrolimus concentrations on acute rejection and toxicity in kidney transplant recipientsDavid J Taber, Mulugeta G Gebregziabher, Titte R Srinivas, et al.
The Annals of Pharmacotherapy|April 26, 2007
Use of bone health protocol to identify and prevent bone disease in kidney and pancreas transplant recipientsDavid J Taber, Elizabeth A Ashcraft, G Mark Baillie, et al.
Clinical Transplantation|February 7, 2013
Pre-existing diabetes significantly increases the risk of graft failure and mortality following renal transplantationDavid J Taber, Holly B Meadows, Nicole A Pilch, et al.
Transplantation|November 29, 2013
Clinical outcomes associated with the early postoperative use of heparin in pancreas transplantationJenna L Scheffert, David J Taber, Nicole A Pilch, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 31, 2012
Leflunomide efficacy and pharmacodynamics for the treatment of BK viral infectionJill C Krisl, David J Taber, Nicole Pilch, et al.
The Annals of Pharmacotherapy|July 1, 2010
Management of hypertension in renal transplant patients: a comprehensive review of nonpharmacologic and pharmacologic treatment strategiesBrianne L Dunn, Ashley C Teusink, David J Taber, et al.
Pharmacotherapy|March 8, 2013
Timing of factor VIIa in liver transplantation impacts cost and clinical outcomesJenna L Scheffert, David J Taber, Nicole A Pilch, et al.
Transplantation Proceedings|June 6, 2012
The impact of early corticosteroid withdrawal on graft survival in liver transplant recipientsH B Meadows, D J Taber, N A Pilch, et al.
Pageof 21

Showing results (91-100 of 209) with videos related to

Sort By:
Pageof 21
Progress in Transplantation (Aliso Viejo, Calif.)|April 12, 2023
A Randomized Control Trial Testing a Medication Safety Dashboard in Veteran Transplant RecipientsDavid J Taber, Sherry Milfred-LaForest, Kelsey Rife, et al.
Primary Care Diabetes|April 30, 2023
Sulfonylureas as second line therapy for type 2 diabetes among veterans: Results from a National Longitudinal Cohort StudyErin R Weeda, Ralph Ward, Mulugeta Gebregziabher, et al.
Pharmacotherapy|May 27, 2015
African-American race modifies the influence of tacrolimus concentrations on acute rejection and toxicity in kidney transplant recipientsDavid J Taber, Mulugeta G Gebregziabher, Titte R Srinivas, et al.
The Annals of Pharmacotherapy|April 26, 2007
Use of bone health protocol to identify and prevent bone disease in kidney and pancreas transplant recipientsDavid J Taber, Elizabeth A Ashcraft, G Mark Baillie, et al.
Clinical Transplantation|February 7, 2013
Pre-existing diabetes significantly increases the risk of graft failure and mortality following renal transplantationDavid J Taber, Holly B Meadows, Nicole A Pilch, et al.
Transplantation|November 29, 2013
Clinical outcomes associated with the early postoperative use of heparin in pancreas transplantationJenna L Scheffert, David J Taber, Nicole A Pilch, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 31, 2012
Leflunomide efficacy and pharmacodynamics for the treatment of BK viral infectionJill C Krisl, David J Taber, Nicole Pilch, et al.
The Annals of Pharmacotherapy|July 1, 2010
Management of hypertension in renal transplant patients: a comprehensive review of nonpharmacologic and pharmacologic treatment strategiesBrianne L Dunn, Ashley C Teusink, David J Taber, et al.
Pharmacotherapy|March 8, 2013
Timing of factor VIIa in liver transplantation impacts cost and clinical outcomesJenna L Scheffert, David J Taber, Nicole A Pilch, et al.
Transplantation Proceedings|June 6, 2012
The impact of early corticosteroid withdrawal on graft survival in liver transplant recipientsH B Meadows, D J Taber, N A Pilch, et al.
Pageof 21